Olverembatinib
HQP1351AG301
Phase 3 small_molecule active
Quick answer
Olverembatinib for Ph+ ALL is a Phase 3 program (small_molecule) at Ascentage Pharma Group with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ascentage Pharma Group
- Indication
- Ph+ ALL
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active